Literature DB >> 23216777

Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma.

Junichi Shindoh1, Kiyoshi Hasegawa, Yosuke Inoue, Takeaki Ishizawa, Rihito Nagata, Taku Aoki, Yoshihiro Sakamoto, Yasuhiko Sugawara, Masatoshi Makuuchi, Norihiro Kokudo.   

Abstract

INTRODUCTION: A high recurrence rate of hepatocellular carcinoma (HCC) remains a significant concern. The risk factors for recurrence were analysed and the optimal surgical approaches were investigated.
METHODS: The subjects comprised 280 consecutive patients with primary solitary HCC measuring ≤5 cm in diameter, who underwent curative resections. Multivariate analysis was conducted to identify the risk factors for post-operative recurrence, and the clinical significance of an anatomic resection was evaluated.
RESULTS: Multivariate analysis identified HCV infection, a des-gamma-carboxyprothrombin level >100 mAU/ml, underlying cirrhosis, the presence of microvascular invasion, the presence of micrometastases and non-anatomic resection as being significant risk factors for post-operative recurrence. The 5-year recurrence rate was 56.7% in the anatomic resection (AR) group and 74.7% in the non-AR group. The 5-year survival rate was 82.2% in the AR group and 71.9% in the non-AR group. Local recurrence within the same segment was observed in 25% of the patients of the non-AR group. The prognostic superiority of AR was confirmed only in patients with histopathological evidence of microvascular invasion and/or micrometastases, and in patients having a solitary HCC measuring 2 to 5 cm in diameter.
CONCLUSIONS: Anatomic resection may decrease local recurrence and improve the surgical outcomes in solitary HCC measuring 2 to 5 cm in diameter.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23216777      PMCID: PMC3533710          DOI: 10.1111/j.1477-2574.2012.00552.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  34 in total

1.  Prognostic impact of anatomic resection for hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo; Hiroshi Imamura; Yutaka Matsuyama; Taku Aoki; Masami Minagawa; Keiji Sano; Yasuhiko Sugawara; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 2.  Hepatocellular carcinoma: current management and perspectives for the future.

Authors:  Nuh N Rahbari; Arianeb Mehrabi; Nathan M Mollberg; Sascha A Müller; Moritz Koch; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

3.  Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.

Authors:  H Imamura; Y Matsuyama; Y Miyagawa; K Ishida; R Shimada; S Miyagawa; M Makuuchi; S Kawasaki
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

Review 4.  Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma.

Authors:  Yanming Zhou; Donghui Xu; Lupeng Wu; Bin Li
Journal:  Langenbecks Arch Surg       Date:  2011-04-08       Impact factor: 3.445

5.  Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.

Authors:  Shinji Tanaka; Kaoru Mogushi; Mahmut Yasen; Norio Noguchi; Atsushi Kudo; Toshiaki Kurokawa; Noriaki Nakamura; Johji Inazawa; Hiroshi Tanaka; Shigeki Arii
Journal:  J Am Coll Surg       Date:  2009-03       Impact factor: 6.113

6.  Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification.

Authors:  Shinichi Ueno; Fumitake Kubo; Masahiko Sakoda; Kiyokazu Hiwatashi; Taro Tateno; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Shoji Natsugoe; Takashi Aikou
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-10-04

7.  Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey.

Authors:  Susumu Eguchi; Takashi Kanematsu; Shigeki Arii; Masatoshi Okazaki; Kiwamu Okita; Masao Omata; Iwao Ikai; Masatoshi Kudo; Masamichi Kojiro; Masatoshi Makuuchi; Morito Monden; Yutaka Matsuyama; Yasuni Nakanuma; Kenichi Takayasu
Journal:  Surgery       Date:  2008-04       Impact factor: 3.982

8.  The impact of anatomical resection for hepatocellular carcinoma that meets the Milan criteria.

Authors:  Toshiya Kamiyama; Kazuaki Nakanishi; Hideki Yokoo; Hirofumi Kamachi; Michiaki Matsushita; Satoru Todo
Journal:  J Surg Oncol       Date:  2010-01-01       Impact factor: 3.454

9.  Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm.

Authors:  Yasuhiko Nagano; Hiroshi Shimada; Kazuhisa Takeda; Michio Ueda; Kenichi Matsuo; Kuniya Tanaka; Itaru Endo; Chikara Kunisaki; Shinji Togo
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

10.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

View more
  34 in total

Review 1.  Simulation and navigation liver surgery: an update after 2,000 virtual hepatectomies.

Authors:  Akinori Miyata; Junichi Arita; Yoshikuni Kawaguchi; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2020-10-31

Review 2.  Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Authors:  Gar-Yang Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Surgical approach for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Junichi Shindoh; Masaji Hashimoto; Goro Watanabe
Journal:  World J Hepatol       Date:  2015-01-27

4.  Stratification of risk of recurrence after curative-intent treatment for small hepatocellular carcinoma.

Authors:  Junichi Shindoh
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

5.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

Review 6.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

7.  Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?

Authors:  Shan Ke; Xue-Mei Ding; Xiao-Jun Qian; Yi-Ming Zhou; Bao-Xin Cao; Kun Gao; Wen-Bing Sun
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

8.  Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma.

Authors:  Chetana Lim; Yoshihiro Mise; Yoshihiro Sakamoto; Satoshi Yamamoto; Junichi Shindoh; Takeaki Ishizawa; Taku Aoki; Kiyoshi Hasegawa; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

9.  Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer.

Authors:  Yu-Long Zhang; You-Cheng Zhang; Wei Han; Yu-Min Li; Geng-Nian Wang; Shao Yuan; Feng-Xian Wei; Jia-Feng Wang; Jian-Jun Jiang; Ya-Wu Zhang
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 10.  Prognostic factors for hepatocellular carcinoma recurrence.

Authors:  Antonio Colecchia; Ramona Schiumerini; Alessandro Cucchetti; Matteo Cescon; Martina Taddia; Giovanni Marasco; Davide Festi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.